إعلان
إعلان
ANTX
AN2 Therapeutics, Inc. Common Stock
1.30
USDبرعاية
+0.20
+18.64%
٠٨ يناير, ١٥:٥٩ UTC -5
مغلق
بعد الإغلاق
1.33
+0.02
+1.61%
تقارير أرباح ANTX
النسبة الإيجابية المفاجئة
ANTX تفوق 9 من 15 آخر التقديرات.
60%
التقرير التالي
بيانات التقرير القادم
١٦ مارس ٢٠٢٦
Estimate for Q4 25 (Revenue/ EPS)
--
/-$0.24
التغير الضمني من Q3 25 (Revenue/ EPS)
--
/-22.58%
التغير الضمني من Q4 24 (Revenue/ EPS)
--
/-4.00%
AN2 Therapeutics, Inc. Common Stock earnings per share and revenue
On ١٢ نوفمبر ٢٠٢٥, ANTX reported earnings of -0.31 USD per share (EPS) for Q3 25, missing the estimate of -0.22 USD, resulting in a -38.15% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a -4.24% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 3 المحللين forecast an EPS of -0.24 USD, with revenue projected to reach -- USD, implying an نقصان of -22.58% EPS, and زيادة of 0.00% in Revenue from the last quarter.
الأسئلة الشائعة
What were AN2 Therapeutics, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, AN2 Therapeutics, Inc. Common Stock reported EPS of -$0.31, missing estimates by -38.15%, and revenue of $0.00, 0% as expectations.
How did the market react to AN2 Therapeutics, Inc. Common Stock's Q3 2025 earnings?
The stock price moved down -4.24%, changed from $1.18 before the earnings release to $1.13 the day after.
When is AN2 Therapeutics, Inc. Common Stock expected to report next?
The next earning report is scheduled for ١٦ مارس ٢٠٢٦.
What are the forecasts for AN2 Therapeutics, Inc. Common Stock's next earnings report?
Based on 3
المحللين, AN2 Therapeutics, Inc. Common Stock is expected to report EPS of -$0.24 and revenue of -- for Q4 2025.
Which companies are reporting earnings today?
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان